Related Experiment Video
Updated: Jun 26, 2026

Voltage-Dependent Potassium Current Recording on H9c2 Cardiomyocytes via the Whole-Cell Patch-Clamp Technique
Published on: November 11, 2022
Intracellular potassium stabilizes human ether-à-go-go-related gene channels for export from endoplasmic reticulum
Lu Wang1, Adrienne T Dennis, Phan Trieu
1Rammelkamp Center for Education and Research, MetroHealth Campus, Case Western Reserve University, Cleveland, Ohio 44109, USA.
Insights
Cardiac glycosides disrupt human ether-à-go-go-related gene (hERG) channel trafficking by inhibiting Na+/K+ pumps, leading to intracellular potassium depletion. This potassium depletion causes a conformational defect in hERG, impairing its cell surface transport.
Area of Science:
- Cardiology
- Molecular Pharmacology
- Cell Biology
Background:
- Therapeutic compounds can prolong QT interval and cause arrhythmias by disrupting hERG channel trafficking.
- Cardiac glycosides are a key class of compounds that inhibit hERG trafficking.
- Previous work linked cardiac glycoside inhibition of hERG trafficking to Na+/K+ pump block.
Purpose of the Study:
- To elucidate the mechanism coupling Na+/K+ pump inhibition to hERG processing.
- To investigate the role of intracellular potassium in hERG trafficking.
- To identify conditions and factors that restore hERG trafficking.
Main Methods:
- Utilized cardiac glycosides and gramicidin to deplete intracellular potassium in cell models.
- Assessed hERG trafficking under conditions of potassium depletion and restoration.
- Investigated the effect of ion permeability, temperature, pharmacological chaperones, and hERG mutations on trafficking.
Main Results:
- Intracellular potassium depletion, induced by cardiac glycosides or gramicidin, disrupts hERG trafficking.
- Restoration of hERG trafficking in potassium-depleted cells was achieved by K+ or Rb+ ion permeation, low temperatures, astemizole, or specific hERG mutations.
- These findings indicate a direct link between intracellular potassium levels and hERG channel conformation.
Conclusions:
- Cardiac glycosides inhibit hERG trafficking via a mechanism involving intracellular potassium depletion.
- The study reveals a novel pathway for drug-induced trafficking inhibition mediated by potassium-dependent conformational changes in the hERG channel.
- Understanding this mechanism is crucial for developing safer therapeutics and managing drug-induced arrhythmias.
Abstract:
Several therapeutic compounds have been identified that prolong the QT interval on the electrocardiogram and cause torsade de pointes arrhythmias not by direct block of the cardiac potassium channel human ether-à-go-go-related gene (hERG) but via disruption of hERG trafficking to the cell surface membrane. One example of a clinically important compound class that potently inhibits hERG trafficking are cardiac glycosides. We have shown previously that inhibition of hERG trafficking by cardiac glycosides is initiated via direct block of Na(+)/K(+) pumps and not via off-target interactions with hERG or any other protein. However, it was not known how pump inhibition at the cell surface is coupled to hERG processing in the endoplasmic reticulum. Here, we show that depletion of intracellular K(+)-either indirectly after long-term exposure to cardiac glycosides or directly after exposure to gramicidin in low sodium media-is sufficient to disrupt hERG trafficking. In K(+)-depleted cells, hERG trafficking can be restored by permeating K(+) or Rb(+) ions, incubation at low temperature, exposure to the pharmacological chaperone astemizole, or specific mutations in the selectivity filter of hERG. Our data suggest a novel mechanism for drug-induced trafficking inhibition in which cardiac glycosides produce a [K(+)](i)-mediated conformational defect directly in the hERG channel protein.
Related Concept Videos
Antiepileptic Drugs: Potassium Channel Activators
Ezogabine has gained approval as an adjunctive treatment...
Primary Active Transport
Primary Active Transport
Ion Channels
Ion channels are specialized integral membrane proteins on the plasma membrane that allow specific...
Non-gated Ion Channels
Compared to the gated ion channels, the non-gated channels, also known as leakage or passive channels, have no gating mechanism.
Non-gated Ion Channels
Compared to the gated ion channels, the non-gated channels, also known as leakage or passive channels, have no gating mechanism.

